A Study Of PF-05190457 In Healthy Volunteers And Type-2 Diabetic Patients
Stopped B3301002 was discontinued on 18 April 2012 for strategic reasons.There were no safety concerns leading to discontinuation of this study.
Conditions
- Diabetes Mellitus, Type 2
Interventions
- DRUG: PF-05190457 or Placebo
- DRUG: PF-05190457 or Placebo
- DRUG: PF-05190457 or Placebo
- DRUG: PF-05190457 or Placebo
- DRUG: PF-05190457 or Placebo
- DRUG: PF-05190457 or Placebo
- DRUG: PF-05190457 or Placebo
Sponsor
Pfizer